
![]() |
How Am I Supposed to Breath with No AIR?:
Global initiative for asthma (GINA) guideline updates for adolescents and adults with mild to moderate asthma
|
J. Skye Mitchell, PharmD, BCACP;
PGY1 Pharmacy Resident,
Prisma Health Greenville
|
![]() |
2024 Update In Diabetes
|
Cynthia Phillips, PharmD, CDCES;
Clinical Associate Professor, USC COP;
Clinical Pharmacist, Prisma Health Richland
|
![]() |
Oh Baby: an OB Primer for the Non-OB Pharmacist
|
Ashton Mason, PharmD;
PGY2 Internal Medicine Pharmacy Resident, Prisma Health Midlands
|
![]() |
Biosimilars Decoded - What's in a Name?
|
Betsy Blake, PharmD, BCPS, FNAP;
Clinical Associate Professor and Director of Interprofessional Education - USC College of Pharmacy;
Clinical Pharmacy Specialist -
Prisma Health Internal Medicine - Saluda Ridge
|
![]() |
Opioids: the Good, the Bad, and the Ugly
|
Tate Owens, PharmD;
Clinical Pharmacist, Tandem Health
|
![]() |
Immunization Update 2024
|
Patricia H. Fabel, PharmD, BCPS, FAPhA;
Clinical Associate Professor, USC College of Pharmacy
|
![]() |
2023 Beers Criteria Update
|
Karen McGee, PharmD, CDCES, BCGP;
Associate Professor, USC College of Pharmacy;
Clinical Pharmacy Specialist, Geriatrics Prisma Health Midlands PACE Whiterock
|
![]() |
Clearing The Fog: Debunking Common Myths in Antibiotic Practices
|
Hana Winders, PharmD, BDICP;
Ambulatory Antimicrobial Stewardship Pharmacist,
Prisma Health Midlands
|
![]() ![]() |
Mythbusters: What's True, What's False, and What's Downright Silly
|
Cory Jenks, PharmD, BCPS, BCACP
Ambulatory Care Clinical Pharmacist
Optum
Kendrick Murphy, PharmD, BCACP
Clinical Pharmacist Practitioner,
PGY1 Pharmacy Residency Program Director
Western North Carolina VA Health Care System |
![]() |
Statin Pharmacogenomics
|
Whitney Maxwell, PharmD, MBA, BCPS;
Clinical Associate Professor, Associate Director of Experiential Education, USC College of Pharmacy
|
![]() |
What is a Brick:
The Power of Divergent Thinking
|
Cory Jenks, PharmD, BCPS, BCACP;
Ambulatory Care Clinical Pharmacist, Optum
|
![]() |
Opioid Stewardship and Overdose Prevention
|
Jordan Marie Ballou, PharmD, BCACP;
Clinical Associate Professor, USC College of Pharmacy
|
|
Hours | Pharmacists** | Pharmacy Technicians |
All programming
(Saturdays, February 10
AND
March 16)
|
12
|
$130L | $60L |
- Active PEEP Preceptors: Prior to registering, please contact us to obtain the coupon code for discounted registration!
- USC College of Pharmacy Alumni: Prior to registering, please contact us to obtain the coupon code for discounted registration!
- L- Please note that fees will appear as “Learning Express” on your credit card statement
- Operating System: Windows, Mac OS and Linux
- Internet Browser: Internet Explorer 7.0 or higher; Mozilla Firefox 3.0 or higher; Google Chrome
- Computer Speakers or headphones connected to your computer
- Broadband Internet Connection: Cable, High-speed DSL or T1
- Monitor Screen Resolution: 320x480 or higher
- Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint and HTML
CE Hours
CE Units
Activity Type
- Knowledge-Based and Application-Based
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
![]() |
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Please choose a Fee Type from the Drop Down Menu Below:
I am a
|
- Apply GINA guidelines to drug therapy decisions for adolescent and adult patients with mild to moderate asthma
- Distinguish the appropriate treatment track based on patient-specific factors
- Employ strategies to educate and encourage patients to adhere to evidence-based treatment plans
- Recognize appropriate therapeutic interchanges for patients using an anti-inflammatory reliever (AIR) or maintenance and reliever therapy (MART)
- Calculate the appropriate day supply for an asthma inhaler written to follow new GINA guidelines
- Identify patients who would benefit from additional counseling from a pharmacist
Speaker(s)/Author(s)
J. Skye Mitchell, PharmD, BCACP
|
Activity Number
0062-0000-24-014-H01-P/T
CE Hours
- Describe approaches to promote positive health behaviors in persons with diabetes
- Discuss individualization of pharmacologic approaches of therapy for diabetes
- Explain challenges associated with use of diabetes technology
Speaker(s)/Author(s)
Cynthia Phillips, PharmD, CDCES
|
Activity Number
0062-0000-24-015-H01-P/T
CE Hours
- Identify common obstetric disease states
- Summarize guideline-directed therapy for common obstetric disease states
- Evaluate evidence-based therapies to optimize care in pregnant patients
- Discuss potential future areas of focus in obstetric pharmacy care
- Identify common obstetric disease states
- Summarize guideline-directed therapy for common obstetric disease states
- Compare therapies to optimize care in pregnant patients
- Discuss potential future areas of focus in obstetric pharmacy care
Speaker(s)/Author(s)
Ashton Mason, PharmD
|
Activity Number
0062-0000-24-016-H01-P/T
CE Hours
- Define common terms associated with biological products
- Describe the nomenclature process for biologics
- Summarize recent updates for biological products
Speaker(s)/Author(s)
Betsy Blake, PharmD, BCPS, FNAP
|
Activity Number
0062-0000-24-017-H01-P/T
CE Hours
- Apply the Opioid Use Disorder (OUD) criteria to evaluate patients who may be suffering from OUD
- Identify common signs of opioid withdrawal and overdose symptoms
- Identify available medications and resources to help aid people who are suffering from OUD
- Recognize South Carolina law on prescribing and filling controlled substances
- Discuss how pharmacists can play a role in helping end the Opioid Crisis
- Apply the Opioid Use Disorder (OUD) criteria to evaluate patients who may be suffering from OUD
- Identify common signs of opioid withdrawal and overdose symptoms
- Identify available medications and resources to help aid people who are suffering from OUD
- Recognize South Carolina law on prescribing and filling controlled substances
Speaker(s)/Author(s)
Tate Owens, PharmD
|
Activity Number
0062-0000-24-018-H08-P/T
CE Hours
- Advocate for patients receiving all recommended immunizations
- Apply updates from the national immunization recommendations to patient cases
- Evaluate recently published vaccine-efficacy studies
- Compare and contrast vaccine products commonly administered in community pharmacies
- Define proper vaccine administration techniques
- Advocate for patients receiving all recommended immunizations
- Explain the technician's role in providing immunizations
- Summarize updates to national immunization recommendations
- List available vaccine products commonly administered in community pharmacies
- Review proper vaccine storage and handling
Speaker(s)/Author(s)
Patricia Fabel, PharmD, BCPS
|
Activity Number
0062-0000-24-019-H06-P/T
CE Hours
- Review changes to 2023 Beers Criteria
- Discuss use of Beer's Criteria in the care of older adults
- Apply Beers Criteria to patient cases
Speaker(s)/Author(s)
Karen McGee, PharmD, CDCES, BCGP
|
Activity Number
0062-0000-24-020-H01-P/T
CE Hours
- Identify common myths in infectious diseases
- Provide evidence debunking common myths in infectious diseases
- Discuss how dispelling common myths in infectious diseases can improve patient care and outcomes
Speaker(s)/Author(s)
Hana Rac Winders, PharmD, BCIDP
|
Activity Number
0062-0000-24-021-H01-P/T
CE Hours
- Articulate how medical myths came into origin
- Discover whether various medical myths are valid
- Apply the tools of Evidence Based Medicine to identify medical myths
Speaker(s)/Author(s)
Cory Jenks, PharmD, BCPS, BCACP
|
|
Kendrick Murphy, PharmD, BCACP
|
Activity Number
0062-0000-24-022-H99-P/T
CE Hours
- Identify key pharmacogenomic variants associated with Statin safety and efficacy
- Evaluate literature describing the clinical impact of pharmacogenetic variants on drug safety, efficacy, and patient outcomes
- Review Clinical Pharmacogenomics Implementation Consortium (CPIC) guidelines and other relevant guidelines for pharmacogenetics-guided dosing recommendations
- Create pharmacotherapy plans for patients based on pharmacogenomic data
- Identify key pharmacogenomic variants associated with Statin safety and efficacy
- Evaluate literature describing the clinical impact of pharmacogenetic variants on drug safety, efficacy, and patient outcomes
- Review Clinical Pharmacogenomics Implementation Consortium (CPIC) guidelines and other relevant guidelines for pharmacogenetics-guided dosing recommendations
Speaker(s)/Author(s)
Whitney Maxwell, PharmD, MBA, BCPS
|
Activity Number
0062-0000-24-023-H01-P/T
CE Hours
- Recognize the difference between convergent and divergent problem solving
- Recall the disadvantages of convergent problem solving
- Identify the advantages of divergent problem solving
Speaker(s)/Author(s)
Cory Jenks, PharmD, BCPS, BCACP
|
Activity Number
0062-0000-24-024-H99-P/T
CE Hours
- Review therapeutic guidelines for pain management and the use of opioids
- Develop workflow best practices for opioid use in a variety of practice settings
- Identify uses of technology to encourage safer opioid practices
- Discuss naloxone for community use, including administration and counseling points
- Identify community resources for assist patients with opioid use disorder
- Develop workflow best practices for opioid use in a variety of practice settings
- Identify uses of technology to encourage safer opioid practices
- Discuss naloxone for community use, including administration instructions and Good Samaritan laws
Speaker(s)/Author(s)
Jordan Marie Ballou, PharmD, BCACP
|
Activity Number
0062-9999-24-025-H08-P/T